{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:04:28Z","timestamp":1770822268221,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1053\/beha.2002.0228","type":"journal-article","created":{"date-parts":[[2003,3,4]],"date-time":"2003-03-04T18:13:53Z","timestamp":1046801633000},"page":"623-638","source":"Crossref","is-referenced-by-count":8,"title":["Results of minimal residual disease (MRD) evaluation and MRD-based treatment stratification in childhood ALL"],"prefix":"10.1053","volume":"15","author":[{"given":"Giovanni","family":"Cazzaniga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"d'Aniello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilia","family":"Corral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2002.0228_RF1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1470-2045(00)00418-6","article-title":"Minimal residual disease in leukemia patients","volume":"2","author":"Szczepanski","year":"2001","journal-title":"Lancet Oncology"},{"key":"10.1053\/beha.2002.0228_RF2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1097-0320(19990815)38:4<139::AID-CYTO1>3.0.CO;2-H","article-title":"Detection of minimal residual disease in acute leukemia by flow cytometry","volume":"38","author":"Campana","year":"1999","journal-title":"Cytometry"},{"key":"10.1053\/beha.2002.0228_RF3","first-page":"21","article-title":"Monitoring minimal residual disease using chromosomal translocations in childhood ALL","volume":"15","author":"Cazzaniga","year":"2002","journal-title":"Bailli\u00e8re's Clinical Haematology"},{"key":"10.1053\/beha.2002.0228_RF4","first-page":"121","article-title":"Detection of minimal residual disease in acute leukemia patients","volume":"2","author":"Van Dongen","year":"1996","journal-title":"Cytokine Molecular Therapy"},{"key":"10.1053\/beha.2002.0228_RF5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.leu.2401245","article-title":"Primers and protocols for standardized MRD detection in ALL using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia","volume":"13","author":"Pongers-Willemse","year":"1999","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0228_RF6","first-page":"657","article-title":"Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B-cell origin","volume":"5","author":"Beishuizen","year":"1991","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0228_RF7","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1182\/blood.V85.10.2795.bloodjournal85102795","article-title":"Heterogeneity of the T cell receptor delta gene indicating subclone formation in acute precursorB cell leukemias","volume":"85","author":"Ghali","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF8","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/sj.leu.2400720","article-title":"Rearrangement status of the malignant cell determines type of secondary IgH rearrangement (V-replacement or V to DJ joining) in childhood B precursor acute lymphoblastic leukemia","volume":"11","author":"Steenbergen","year":"1997","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0228_RF9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1182\/blood.V79.1.223.223","article-title":"VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia","volume":"79","author":"Wasserman","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1182\/blood.V82.2.581.581","article-title":"Distinct ongoing Ig heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia","volume":"82","author":"Steenbergen","year":"1993","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF11","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1182\/blood.V83.8.2238.2238","article-title":"Analysis of Ig and T cell receptor genes in 40 childhood acute lymphoblastic leukemia at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis","volume":"83","author":"Beishuizen","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF12","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1182\/blood.V83.5.1355.1355","article-title":"A polymerase chain reaction study of the stability of Ig heavy-chain and T cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia","volume":"83","author":"Steward","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF13","first-page":"60","article-title":"Characterisation of non-concordance in the T cell receptor gamma chain genes at presentation and clinical relapse in acute lymphoblastic leukemia","volume":"8","author":"Taylor","year":"1994","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0228_RF14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2141.1995.tb03384.x","article-title":"Assessment of clonal evolution at Ig\/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods: implication for a general strategy of minimal residual disease detection","volume":"90","author":"Baruchel","year":"1995","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0228_RF15","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1182\/blood.V87.6.2506.bloodjournal8762506","article-title":"Clonal evolution in B-lineage acute lymphoblastic leukemia by contemporaneous VH\u2013VH gene replacements and VH\u2013DJH gene rearrangements","volume":"87","author":"Choi","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/sj.leu.2401269","article-title":"Clonal stability in children with acute lymphoblastic leukemia (ALL) who relapsed five or more years after diagnosis","volume":"13","author":"Lo Nigro","year":"1999","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0228_RF17","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","article-title":"Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood","volume":"352","author":"Van Dongen","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/beha.2002.0228_RF18","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/sj.leu.2401592","article-title":"Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia","volume":"13","author":"van Dongen","year":"1999","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0228_RF19","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1038\/sj.leu.2400904","article-title":"Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease","volume":"11","author":"Beishuizen","year":"1997","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0228_RF20","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1182\/blood.V73.8.2133.2133","article-title":"T-cell receptor delta gene rearrangements in childhood T-cell acute lymphoblastic leukemia","volume":"73","author":"Biondi","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF21","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1182\/blood.V75.9.1834.1834","article-title":"High prevalence of T-cell receptor V delta 2-(D)-D delta 3 or D delta 1\/2-D delta 3 rearrangements in B-precursor acute lymphoblastic leukemias","volume":"75","author":"Biondi","year":"1990","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0009-8981(91)90247-A","article-title":"Analysis of immunoglobulin and T cell receptor genes. Part II: possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders","volume":"198","author":"van Dongen","year":"1991","journal-title":"Clinical Chimica Acta"},{"key":"10.1053\/beha.2002.0228_RF23","first-page":"2228","article-title":"Detection of immunoglobulin kappa light-chain gene rearrangement patterns by Southern blot analysis","volume":"8","author":"Beishuizen","year":"1994","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0228_RF24","first-page":"2004","article-title":"tal-1 deletions in T cell acute lymphoblasticleukemia as PCR target for detection of minimal residual disease","volume":"7","author":"Breit","year":"1993","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0228_RF25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2141.1996.d01-1917.x","article-title":"Simplified strategies for minimal residual disease detection in B cell precursor acute lymphoblastic leukaemia","volume":"95","author":"Landman-Parker","year":"1996","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0228_RF26","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1182\/blood.V83.11.3271.3271","article-title":"Heteroduplex analysis of T-cell receptor gamma gene rearrangements for diagnosis and monitoring of cutaneous T-cell lymphomas","volume":"83","author":"Bottaro","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF27","first-page":"382","article-title":"Rapid detection of clonality in patients with acute lymphoblastic leukemia","volume":"86","author":"Germano","year":"2001","journal-title":"Haematologica"},{"key":"10.1053\/beha.2002.0228_RF28","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1101\/gr.6.10.986","article-title":"Real time quantitative PCR","volume":"6","author":"Heid","year":"1996","journal-title":"Genome Research"},{"key":"10.1053\/beha.2002.0228_RF29","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1038\/sj.leu.2401246","article-title":"Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes","volume":"12","author":"Pongers-Willemse","year":"1998","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0228_RF30","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/sj.leu.2401801","article-title":"Application of germline IgH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia","volume":"14","author":"Verhagen","year":"2000","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0228_RF31","first-page":"3281","article-title":"Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology","volume":"60","author":"Nakao","year":"2000","journal-title":"Cancer Research"},{"key":"10.1053\/beha.2002.0228_RF32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/abio.1996.9916","article-title":"Product differentiation by analysis of DNA melting curves during the polymerase chain reaction","volume":"245","author":"Ririe","year":"1997","journal-title":"Analytical Biochemistry"},{"key":"10.1053\/beha.2002.0228_RF33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/sj.leu.2401655","article-title":"Potential of Light Cycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"14","author":"Eckert","year":"2000","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0228_RF34","first-page":"3171","article-title":"LightCycler Technology for the quantification of bcr\/abl fusion transcripts","volume":"59","author":"Kreuzer","year":"1999","journal-title":"Cancer Research"},{"key":"10.1053\/beha.2002.0228_RF35","first-page":"23","article-title":"Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes","volume":"87","author":"Bolufer","year":"2002","journal-title":"Haematologica"},{"key":"10.1053\/beha.2002.0228_RF36","first-page":"233a","article-title":"Comparison between TaqMan and LightCycler technology for detection of minimal residual disease in childhood ALL","volume":"I","author":"Cazzaniga","year":"2001","journal-title":"Hematol J"},{"key":"10.1053\/beha.2002.0228_RF37","first-page":"651","article-title":"Molecular pathogenesis of childhood acute lymphoblastic leukemia","volume":"83","author":"Biondi","year":"1998","journal-title":"Haematologica"},{"key":"10.1053\/beha.2002.0228_RF38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2141.1999.01365.x","article-title":"Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis","volume":"105","author":"Foroni","year":"1999","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0228_RF39","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199808273390904","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"339","author":"Cave","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0228_RF40","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1365-2141.1997.1792996.x","article-title":"A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse","volume":"98","author":"Jacquy","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0228_RF41","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-2141.1994.tb04910.x","article-title":"PCR assessment of bone marrow status in \u2018isolated\u2019 extramedullary relapse of childhood B-precursor acute lymphoblastic leukaemia","volume":"87","author":"Goulden","year":"1994","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0228_RF42","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)10295-1","article-title":"Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia","volume":"351","author":"Coustan-Smith","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/beha.2002.0228_RF43","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1182\/blood.V99.6.1952","article-title":"Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia","volume":"99","author":"Dworzak","year":"2002","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF44","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1038\/sj.leu.2401922","article-title":"Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features","volume":"14","author":"Biondi","year":"2000","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0228_RF45","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V95.3.790.003k48_790_794","article-title":"Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia","volume":"95","author":"Panzer-Grumayer","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2002-01-0006","article-title":"Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia","volume":"100","author":"Coustan-Smith","year":"2002","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF47","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1182\/blood.V78.3.739.739","article-title":"Detection of minimal residual disease in T-cell acute relapse","volume":"78","author":"Neale","year":"1991","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF48","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood.V90.3.1226","article-title":"Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia","volume":"90","author":"Dibenedetto","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF49","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1182\/blood.V99.12.4386","article-title":"Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL","volume":"99","author":"Willemse","year":"2002","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF50","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199506153322407","article-title":"Childhood leukaemias","volume":"332","author":"Pui","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0228_RF51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/372143a0","article-title":"Chromosomal translocations in human cancer","volume":"372","author":"Rabbitts","year":"1994","journal-title":"Nature"},{"key":"10.1053\/beha.2002.0228_RF52","first-page":"311a","article-title":"European standardization and quality control program of Real Time Quantitative RT-PCR analysis of fusion gene transcripts for minimal residual disease detection in leukaemia patients","volume":"96","author":"Gabert","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0889-8588(05)70198-2","article-title":"Philadelphia chromosome-positive acute lymphocytic leukemia","volume":"15","author":"Radich","year":"2001","journal-title":"Hematology\/Oncology Clinics of North America"},{"key":"10.1053\/beha.2002.0228_RF54","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJM200004063421402","article-title":"Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"342","author":"Arico","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0228_RF55","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2141.2002.03838.x","article-title":"Prospective molecular monitoring of BCR\/ABL transcript in children with Ph+ acute lymphoblastic leukemia (ALL) unravels differences in treatment response","author":"Cazzaniga","year":"2002","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0228_RF56","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1365-2141.1999.01605.x","article-title":"Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction","volume":"106","author":"Mitterbauer","year":"1999","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0228_RF57","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1034\/j.1600-0609.2000.065004258.x","article-title":"Real-time quantitation of bcr-abl transcripts in haematological malignancies","volume":"65","author":"Saffroy","year":"2000","journal-title":"European Journal of Haematology"},{"key":"10.1053\/beha.2002.0228_RF58","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1073\/pnas.92.11.4917","article-title":"Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia","volume":"92","author":"Golub","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2002.0228_RF59","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood.V85.12.3662.bloodjournal85123662","article-title":"The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion","volume":"85","author":"Romana","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF60","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.V90.2.571","article-title":"Incidence and clinical relevance of TEL\/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicentre therapy trials","volume":"90","author":"Borkhardt","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF61","first-page":"462a","article-title":"Prospective evaluation of t(12;21) prognostic impact in childhood ALL. Results of the Italian ALL-AIEOP 95 therapy protocol","volume":"96","author":"Cazzaniga","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF62","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1046\/j.1365-2141.2000.02464.x","article-title":"Analysis of ETV6\/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value","volume":"111","author":"Codrington","year":"2000","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0228_RF63","first-page":"1985","article-title":"TEL\/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with excellent prognosis","volume":"9","author":"Shurtleff","year":"1995","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0228_RF64","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1182\/blood.V88.11.4252.bloodjournal88114252","article-title":"TEL\/AML-1 dimerises and is associated with a favorable outcome in childhood acute lymphoblastic leukemia","volume":"88","author":"McLean","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF65","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1182\/blood.V92.12.4792","article-title":"Incidence of TEL-AML1 fusion in children with relapsed acute lymphoblastic leukemia","volume":"92","author":"Loh","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF66","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1182\/blood.V90.12.4933","article-title":"Incidence of TEL\/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse","volume":"90","author":"Harbott","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF67","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1182\/blood.V91.5.1716.1716_1716_1722","article-title":"TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia","volume":"91","author":"Seeger","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF68","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1046\/j.1365-2141.2000.02434.x","article-title":"Minimal residual disease studies are beneficial in the follow-up of TEL\/AML1 patients with B-precursor acute lymphoblastic leukaemia","volume":"111","author":"de Haas","year":"2000","journal-title":"Journal of Haematology"},{"key":"10.1053\/beha.2002.0228_RF69","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1182\/blood.V92.12.4792","article-title":"Incidence of TEL-AML1 fusion in children with relapsed acute lymphoblastic leukemia","volume":"92","author":"Loh","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0228_RF70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.leu.2401257","article-title":"Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favourable prognosis for this genetic subgroup","volume":"13","author":"Rubnitz","year":"1999","journal-title":"Leukemia"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692602902288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692602902288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T06:47:41Z","timestamp":1704782861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692602902288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["S1521692602902288"],"URL":"https:\/\/doi.org\/10.1053\/beha.2002.0228","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}